Dernières nouvelles pour Globus Medical (NYSE:GMED) Stock

Globus Medical

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

Globus Medical, Inc. Class A Common Stock

Globus Medical Inc

At the Siggraph Asia 2024 conference in Tokyo, Sony Group Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) introduced a new feature for PlayStation VR2: controller-free <a href="https://www.benzinga.com/general/gaming">hand tracking. </a>
The demo, which quickly made its way to social media, showed users participating in a mini-game using hand gestures instead of traditional controllers.
<h3 class="wp-block-heading">What The Demo Shows</h3>
In the demo, the system tracks the user&#8217;s hand movements and gestures, with no controllers involved. 
See Also: <a href="https://www.benzinga.com/24/12/42320697/277-jobs-cut-as-ubisoft-ends-xdefiant-development">277 Jobs Cut As Ubisoft Ends XDefiant Development</a>
<a href="https://www.eurogamer.net/psvr2-now-has-ability-for-controller-free-hand-tracking">According</a> to Eurogamer, the text accompanying the demo explained that the hand tracking technology &#8220;tracks the position and posture&#8221; of the hands, and it operates at 60 fps with &#8220;low latency.&#8221; 
Sony also mentioned that the system can recognize 12 different gestures. This feature is now available with the latest SDK for PlayStation 5.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">PlayStation VR2 hand tracking in action. <a href="https://twitter.com/hashtag/PSVR2?src=hash&amp;ref_src=twsrc%5Etfw">#PSVR2</a> <a href="https://t.co/THPXkuJfqg">pic.twitter.com/THPXkuJfqg</a>
&mdash; PlayStation VR News (@PS4VRNews) <a href="https://twitter.com/PS4VRNews/status/1864203088493482033?ref_src=twsrc%5Etfw">December 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<h3 class="wp-block-heading">Why This Matters For PS VR2</h3>
<a href="https://www.benzinga.com/general/gaming/24/07/39966966/playstation-vr2-expands-to-pc-in-august-with-new-steam-app">PS VR2</a> has not previously offered hand tracking, and this new demo gives users a glimpse into what that could mean for future VR experiences. 
While systems like the Meta Quest 2 and 3 already offer hand tracking as a standard feature, this is a first for PlayStation VR2.
Sony hasn't provided details on when this feature will be available to PS VR2 owners or how it will be integrated into games, but the demo suggests it could be a valuable addition to the platform.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42310501/playstation-bosses-speaks-about-the-future-of-ai-in-gaming-why-human-creativity-will-always-be-essential-in-game-development">PlayStation Bosses Discuss Future Of AI In Gaming: Why Human Creativity Will Always Be Essential In Game Development</a></li>
</ul>
Image credits: Shutterstock.

Gaming

News

General

Sony Group Corporation American Depositary Shares

SONY

PS VR2 Gets Controller-Free Hand Tracking Feature

<figure class="wp-block-image aligncenter size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="587" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03231757/Leveraged-ETFs-1024x587.jpg" alt="" class="wp-image-3795" style="width:920px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03231757/Leveraged-ETFs-1024x587.jpg 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03231757/Leveraged-ETFs-300x172.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03231757/Leveraged-ETFs-768x440.jpg 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03231757/Leveraged-ETFs.jpg 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h2 class="wp-block-heading">Serving Conservative Investors Too</h2>
In the Portfolio Armor trading Substack, we lean toward aggressive trades, like buying shares of&nbsp;Super Micro Computer, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) at $21.86 after its auditor quit.&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x26a1;&#xFE0F; Turning Bullish On Supermicro &#x26a1;&#xFE0F; Closing out the short half of our trade on <a href="https://twitter.com/search?q=%24SMCI&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$SMCI</a> from Friday and letting the long half run. <a href="https://t.co/r9gyTUCibd">https://t.co/r9gyTUCibd</a>
&mdash; Portfolio Armor (@PortfolioArmor) <a href="https://twitter.com/PortfolioArmor/status/1858601078377378049?ref_src=twsrc%5Etfw">November 18, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
But the Portfolio Armor website offers something else for risk-averse investors. They can enter a dollar amount and their risk tolerance, and the site constructs a concentrated, hedged portfolio for them. That portfolio is designed to maximize the investor&#8217;s returns, while strictly limiting their risk to the maximum drawdown the investor indicated.&nbsp;
Here&#8217;s an example that surprisingly included a leveraged, single-stock ETF.&nbsp;
<h2 class="wp-block-heading">Hedged Portfolio For A Risk-Averse Small Investor</h2>
This was the hedged portfolio our site created 6 months ago for an investor with $30,000 who was unwilling to risk a decline of more than 13% over the next 6 months.&nbsp;
<figure class="wp-block-image aligncenter size-full"><img loading="lazy" decoding="async" width="778" height="846" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03232231/Hedged-Portfolio.png" alt="" class="wp-image-3796" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03232231/Hedged-Portfolio.png 778w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03232231/Hedged-Portfolio-276x300.png 276w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03232231/Hedged-Portfolio-768x835.png 768w" sizes="(max-width: 778px) 100vw, 778px" /><figcaption class="wp-element-caption">Screen capture via Portfolio Armor on 5/23/2024</figcaption></figure>
The investor just entered that he had $30,000 and his maximum tolerable drawdown was 13%, and the site did the rest. It started by allocating equal dollar amounts into hedged positions in&nbsp;The Cooper Companies&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>) and&nbsp;Robinhood Markets Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), which were top names of ours at the time. Then it rounded those dollar amounts down to round lots of each name. Afterwards, it allocated most of the cash left over from that rounding process to the&nbsp;Granite Shares 2x Long COIN Daily ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CONL#NASDAQ">CONL</a>). That ETF is a 2x leveraged play on&nbsp;Coinbase Global, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>).&nbsp;
<h2 class="wp-block-heading">How That Hedged Portfolio Performed&nbsp;</h2>
Over the next six months, that portfolio finished up 23.18%, versus up 13.94% for the&nbsp;SPDR S&amp;P 500 Trust&nbsp;(SPY).&nbsp;
<figure class="wp-block-image aligncenter size-full"><a href="https://portfolioarmor.com/front_tests/5757"><img loading="lazy" decoding="async" width="867" height="842" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03232634/Portfolio-Performance.png" alt="" class="wp-image-3797" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03232634/Portfolio-Performance.png 867w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03232634/Portfolio-Performance-300x291.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03232634/Portfolio-Performance-768x746.png 768w" sizes="(max-width: 867px) 100vw, 867px" /></a><figcaption class="wp-element-caption">Screen capture via Portfolio Armor</figcaption></figure>
You can find an interactive version of that chart <a href="https://portfolioarmor.com/front_tests/5757" target="_blank" rel="noreferrer noopener nofollow">here</a>. If you click there and move your mouse pointer to the beginning of the period, May 23rd, you&#8217;ll see the net position value for CONL (underlying + the long put leg &#8211; the short call leg) was $3,806.85. When the portfolio ended, that net position value was $4,286.70, as you can see in the image above, representing a gain of 11%. The point of that tightly-collared CONL position was to get a better-than-cash return while not increasing the portfolio&#8217;s risk, and it did just that. 
<h2 class="wp-block-heading">If You&#8217;d Rather Hedge What You Already Have&nbsp;</h2>
As a reminder, you can download our iPhone hedging app by clicking on the QR code below. You can also aim your iPhone camera at it.
<figure class="wp-block-image size-full"><a href="https://apps.apple.com/us/app/portfolio-armor/id394951144"><img loading="lazy" decoding="async" width="200" height="197" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03232829/QR-Code.jpg" alt="" class="wp-image-3798" /></a></figure>
Want a heads up next time we place an aggressive trade? You can subscribe to our trading Substack/occasional email list below.&nbsp;
If you&#8217;d like to stay in touch
You can scan for optimal hedges for individual securities, find our current top ten names, and&nbsp;create hedged portfolios&nbsp;on&nbsp;<a href="https://portfolioarmor.com/">our website</a>.&nbsp;You can also follow Portfolio Armor on X&nbsp;<a href="https://twitter.com/portfolioarmor">here</a>, or become a free subscriber to our trading Substack using the link below (we&#8217;re using that for our occasional emails now).
<figure class="wp-block-image aligncenter size-full"><a href="https://portfolioarmor.substack.com/"><img loading="lazy" decoding="async" width="602" height="418" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03233024/Widget.jpg" alt="" class="wp-image-3799" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03233024/Widget.jpg 602w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/03233024/Widget-300x208.jpg 300w" sizes="(max-width: 602px) 100vw, 602px" /></a></figure>

Specialty ETFs

ETFs

COIN

GraniteShares 1.5x Long Coinbase Daily ETF

CONL

HOOD

SMCI

A Surprising Use For A Leveraged, Single-Stock ETF

U.S. economic activity rose slightly in November, with three of the Federal Reserve's 12 districts reporting modest or moderate growth, offsetting two districts with flat or slightly declining activity, according to the Fed's latest <a href="https://www.benzinga.com/topic/beige-book">Beige Book report.</a>
The Wednesday <a href="https://www.federalreserve.gov/monetarypolicy/files/BeigeBook_20241204.pdf">report</a>, which is one of eight released by the Fed annually, reported growth in economic activity and expectations for continued growth across geographies and sectors.
Businesses have optimism that demand will rise in the coming months, the report said.
Key Insights From November Fed Beige Book
Consumer spending was stable: Businesses that are consumer-oriented reported sensitivity to price increases and more focus on quality. Softer sales were reported by restaurants as consumers held back on spending for this segment. Apparel and snowmobiles also saw weakened sales in the period due to the weather.
Low Mortgage demand: The report found that mortgage demand was low with home loan demand mixed during the reporting period across districts.
Farm equipment: One of the key takeaways from the report is farm equipment sales being a headwind on investment activity with concerns that the prices of the equipment could see weakened demand continue given weakness in the farm economy.
Energy activity: The oil and gas sector was flat for the November period, but demand for electricity generation experienced a sharp increase, the report said. Rapid expansion of data centers and investments in renewable generation capacity were themes in the report.
Employment: A slowdown in hiring demand was reported, but employment held steady for the period with wage increases listed as "modest." Lower worker turnover in the reporting period and fewer layoffs may have contributed to lower hiring demand.
Outlook: The Beige Book shows a neutral outlook with some businesses still expressing uncertainty about the direction of the economy.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/09/40716207/fed-beige-book-economic-activity-slows-as-9-districts-report-flat-or-declining-tr">Fed Beige Book August: Economic Activity Slows As 9 Districts Report Flat Or Declining Trends, Consumer Spending Weakens</a>
District-Specific Developments
Boston: Economic activity down slightly, while prices increased and employment held steady. Warmer weather led to decreased spending at restaurants and on select goods.
New York: Economic activity expanded slightly, led by growth in the manufacturing sector. Employment in the region was up slightly, with moderate wage growth.
Philadelphia: Economic activity was up after falling slightly in the last period. Growth in the nonmanufacturing sector helped offset flat consumer spending.
Cleveland: Economic activity grew modestly in November, with the outlook expecting increased activity ahead. Employment levels were up slightly and nonresidential construction activity increased.
Richmond: Economic activity grew slightly despite the port worker strike and Hurricane Helene impacting the region.
Atlanta: Economic activity grew during the reporting period with retail sales improving slightly. Employment was steady and wages grew slightly for the region.
Chicago: Economic activity grew slightly with consumer and business spending rising during the period. Construction and real estate activity was flat for the district.
St. Louis: Economic activity slightly increased with prices increasing moderately. Businesses in the region noted increases in inventories ahead of potential import tariffs.
Minneapolis: Economic activity increased slightly alongside employment growth. Commercial and residential real estate saw growth in the district.
Kansas City: Economic activity was modest with balance across sectors. The outlook for consumer spending was strong for the district.
Dallas: Economic activity rose moderately, with growth in nonfinancial services, manufacturing, and retail. The district saw increased employment and higher wage growth.
San Francisco: Economic activity was stable. Manufacturing, residential real estate and financial services increased in the reporting period.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41823887/powell-dismisses-talk-of-resignation-after-trump-victory-says-policy-is-still-res">Powell Dismisses Talk Of Resignation After Trump Victory, Says &#8216;Policy Is Still Restrictive&#8217;</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Topics

Econ #s

Economics

Fed Beige Book: Economic Growth Climbs, Consumer Spending Steady, Hiring Momentum Slows

Star Bulk Carriers's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBLK#NYSE">SBLK</a>) short percent of float has fallen 4.65% since its last report. The company recently reported that it has 1.39 million shares sold short, which is 1.23% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.09 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Star Bulk Carriers Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733343322_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Star Bulk Carriers has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Star Bulk Carriers's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Star Bulk Carriers's peer group average for short interest as a percentage of float is 2.76%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

SBLK

Looking Into Star Bulk Carriers's Recent Short Interest

Trane Technologies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TT#NYSE">TT</a>) short percent of float has risen 11.22% since its last report. The company recently reported that it has 2.44 million shares sold short, which is 1.09% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.81 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Trane Technologies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733343317_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Trane Technologies has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Trane Technologies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Trane Technologies's peer group average for short interest as a percentage of float is 3.60%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Trane Technologies?

Medifast's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) short percent of float has fallen 3.48% since its last report. The company recently reported that it has 1.60 million shares sold short, which is 22.18% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.81 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Medifast Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733343311_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Medifast has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Medifast's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Medifast's peer group average for short interest as a percentage of float is 4.48%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Medifast's Recent Short Interest

WIIM

MP Materials shares are trading lower as the stock possibly pulls back from yesterday's strength following reports that China banned exports of gallium, germanium and antimony to the United States.

On Wednesday, Atea Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVIR#NASDAQ">AVIR</a>) released Phase 2 study data from the regimen of bemnifosbuvir and ruzasvir for the hepatitis C virus infection that causes liver swelling and&nbsp;can lead to <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42311325/atea-pharmaceuticals-announces-positive-results-from-phase-2-study-of-bemnifosbuvir-and-ruzasvir-r" rel="noreferrer noopener">serious liver damage</a>.
The study met its primary endpoints of safety and sustained virologic response at 12 weeks post-treatment (SVR12).
Primary endpoint results demonstrated a 98% (208/213) SVR12 rate in the per-protocol treatment adherent patient population after eight weeks of treatment with a regimen of bemnifosbuvir and ruzasvir.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/40860512/atea-pharmaceuticals-covid-19-treatment-flunks-in-late-stage-study-blames-constantly-evolving-vir" rel="noreferrer noopener">Atea Pharmaceuticals&#8217; COVID-19 Treatment Flunks In Late-Stage Study, Blames&#8217; Constantly Evolving&#8217; Virus</a>
The efficacy evaluable patient population, which included 17% treatment non-adherent patients, achieved a 95% (242/256) SVR12 rate demonstrating the potency and forgiveness of the regimen.
In June, Atea Pharmaceuticals shared new data from the lead-in cohort (n=60) of its ongoing Phase 2 combination study of bemnifosbuvir and ruzasvir for&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/06/39186949/atea-pharmaceuticals-shares-promising-data-from-therapy-study-for-hepatitis-c-virus" rel="noreferrer noopener">hepatitis C virus</a>.
The regimen was generally safe and well-tolerated, with no drug-related serious adverse events or treatment discontinuations.
Full data for the Phase 2 study will be presented at a scientific meeting during the first half of 2025.
In the Phase 2 study, 99% (178/179) of treatment-adherent patients who were non-cirrhotic and infected with genotypes 1-4 achieved SVR12, demonstrating robust pan-genotypic potency and supporting an eight-week treatment in the Phase 3 program.
Treatment adherent patients with cirrhosis achieved a 88% (30/34) SVR12 rate.
Viral kinetics were slower in these cirrhotic patients. However, all patients achieved 100% end-of-treatment response. To maximize efficacy, the Phase 3 program will extend treatment duration to 12 weeks in patients with cirrhosis.
Atea is preparing for the Phase 3 program, which is expected to follow an End of Phase 2 meeting with the FDA anticipated for early 2025.
The Phase 3 program is expected to use a fixed-dose combination tablet, reducing the daily pill count from four to two tablets and enhancing patient convenience, with no food effect.
Price Action: AVIR stock is down 9.63% at $3.15 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/contracts/24/12/42321722/southland-holdings-lands-60m-wastewater-deal-details" target="_blank" rel="noreferrer noopener">Southland Holdings Lands $60M Wastewater Deal: Details</a></li>
</ul>

Biotech

Health Care

Movers

AVIR

After Failed COVID-19 Drug Trial, Atea Pharmaceuticals Touts Encouraging Data From Mid-Stage Hepatitis C Study

<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="628" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/04201018/image-1024x628.png" alt="" class="wp-image-3818" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/04201018/image-1024x628.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/04201018/image-300x184.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/04201018/image-768x471.png 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/04201018/image.png 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">Making Money From Crowd Stampede</h4>
Chart of Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>). 
Note the following:
<ul>
<li>This article is about the big picture, not an individual stock. The chart of PLTR is being used to illustrate the point.&nbsp;&nbsp;</li>
<li>The chart shows that PLTR stock has gone vertical.&nbsp;&nbsp;</li>
<li>The chart shows that the Arora core position was bought at $20.15.&nbsp;&nbsp;</li>
<li>The chart shows when the Arora trade around position signal was given.&nbsp; A trade around position is a technique used by billionaires and hedge funds that can dramatically increase returns and reduce risks.&nbsp;&nbsp;</li>
<li>As full disclosure, The Arora Report system is close to giving another signal for a new trade around position on PLTR.&nbsp; </li>
<li>Palantir is a defense contractor providing mostly AI-based software.&nbsp;</li>
<li>Being a defense contractor is a complex business.&nbsp; Historically, it has taken defense contractors a very long period, many acquisitions, and storied histories to become large.&nbsp;&nbsp;&nbsp;</li>
<li>With Palantir, it is the first time that a company has become the largest defense contractor by market cap in the blink of an eye.&nbsp; More remarkable is that Palantir has achieved this feat not through a long storied history and not through acquisitions.&nbsp; Palantir has reached this status through a momo crowd and meme crowd stampede.&nbsp;&nbsp;&nbsp;</li>
<li>The chart shows that money is to be made by taking advantage of momo crowd and meme crowd stampedes.&nbsp; Over the years, we have helped our members make money from these stampedes on a number of stocks.&nbsp; Of course, prudent investors should have risk controls in place and be patient.&nbsp;&nbsp;</li>
<li>As full disclosure, PLTR was recently added to the ZYX Buy Core Model Portfolio.&nbsp;&nbsp;As full disclosure, Rtx Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>)&nbsp;is also in the ZYX Buy Core Model Portfolio.</li>
<li>RTX is the second largest defense contractor now by market cap.&nbsp;&nbsp;</li>
<li>Here is a comparison of a few key metrics between PLTR and RTX.
<ul>
<li>PLTR trailing PE is 354.&nbsp; RTX trailing PE is 34.</li>
<li>PLTR forward PE is 151.&nbsp; RTX forward PE is 19.&nbsp;</li>
<li>PLTR price/sales is 65.&nbsp; RTX price/sales is 2.&nbsp;</li>
</ul>
</li>
<li>Based on the&nbsp;<a href="https://thearorareport.com/zyxmethod">ZYX Change Method</a>&nbsp;<a href="https://thearorareport.com/zyx-quantitative-screen">quantitative screen</a>, the highest reasonable valuation of PLTR is under $40.&nbsp; PLTR is trading at $71.74 as of this writing in the premarket.&nbsp;</li>
<li>The very long term Arora target for PLTR is $123 &#8211; $136.&nbsp;</li>
<li>The foregoing also illustrates the extreme positive sentiment in the stock market.&nbsp;</li>
<li>This morning, the stock market is front running Fed Chair Powell.&nbsp; Powell will be speaking later today.&nbsp; The hopium is that Powell will be dovish and indicate a rate cut is coming in spite of a large set of data showing that it is imprudent to cut rates at this time.</li>
<li>Buying in the early trade is largely focused on large cap tech stocks as well as speculative junk stocks.&nbsp;&nbsp;</li>
<li>Also adding to the buying are comments on Salesforce Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) and Marvell Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) conference calls regarding AI.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
</ul>
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are positive in Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Alphabet Inc Class C (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>), Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), and Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
In the early trade, money flows are negative in Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>).
In the early trade, money flows are positive in SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.&nbsp; Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.&nbsp; The most popular ETF for gold is SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>).&nbsp; The most popular ETF for silver is iShares Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLV#NYSE">SLV</a>).&nbsp; The most popular ETF for oil is United States Oil ETF (ASCA:USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is range bound.&nbsp;
<h4 class="wp-block-heading">Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.&nbsp;&nbsp;The proprietary protection band from The Arora Report is very popular.&nbsp; The protection band puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors.&nbsp;
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp;&nbsp;When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

$BTC

AAPL

AMZN

GOOG

MRVL

MSFT

NVDA

PLTR

TSLA

Making Money From Crowd Stampede – Palantir Becomes Largest Defense Contractor In Blink Of An Eye

Michigan is on the brink of achieving a milestone as one of the nation&#8217;s <a href="https://www.benzinga.com/markets/cannabis/24/06/39334493/michigan-remains-top-seller-of-cannabis-in-us-despite-slower-sales-in-may">most dynamic</a> cannabis markets: $10 billion in total sales within just five years of legalizing recreational marijuana. 
In a recent Politico <a href="https://www.politico.com/news/2024/12/04/brian-hanna-michigan-weed-market-interview-00192456">interview</a> by Paul Demko, Brian Hanna, executive director of Michigan's Cannabis Regulatory Agency (CRA), credits this growth to balancing regulatory oversight with adaptability to the evolving needs of the industry.
<h3 class="wp-block-heading">Driving Record Sales While Cutting Costs</h3>
"We're breaking sales records every quarter, but that's just a piece of the story," Hanna explained. &#8220;At the end of the day, we're trying to adapt with the industry, learn what should be regulated, and what cuts we can make to save businesses money." 
One example of such changes is the CRA's decision to eliminate mandatory lobbies for cannabis retailers—a seemingly minor adjustment that significantly reduces operational costs for businesses.
Hanna noted that the agency has prioritized open communication with stakeholders. &#8220;We've been working on new rules since May of 2023. We got a lot of feedback, hundreds and hundreds of emails and phone calls and live testimony during public sessions.&#8221;
This strategy is relevant due to the fact that, despite sales thriving, prices have <a href="https://www.benzinga.com/markets/cannabis/24/10/41411086/michigans-cannabis-market-faced-with-oversupply-and-falling-prices">plummeted</a> in recent months, making things harder for companies.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/10/41170083/michigan-cannabis-market-hits-record-sales-amid-low-weed-prices-and-rise-in-cultivation-licenses">Michigan Cannabis Market Hits Record Sales Amid Low Weed Prices And Rise In Cultivation Licenses</a>
<h3 class="wp-block-heading">Tackling Illicit Markets And Regulatory Challenges</h3>
<a href="https://www.benzinga.com/topic/michigan">Michigan</a> faces similar challenges seen across the U.S., including <a href="https://www.benzinga.com/markets/cannabis/24/09/41002430/illicit-cannabis-market-balloons-to-79-billion-is-rescheduling-enough-to-fix-the-system">illicit sales</a> and product diversion. 
"We are tackling the most egregious behavior aggressively by putting it out in the public for a couple reasons,&#8221; Hanna said. &#8220;One, to show people that we're working towards these efforts; and two, to show those that are thinking about doing these illicit, egregious behaviors that we're paying attention."
One tool Michigan is developing is a state reference laboratory, which will speed up investigations into illicit products while auditing licensed labs and product compliance. 
"It takes 45 days right now at a minimum to investigate Illicit material in the market. We think we can really speed up that process of investigations with the reference lab. But we also want to audit licensed labs," said Hanna.
Lab shopping and <a href="https://www.benzinga.com/markets/cannabis/24/07/40046373/fake-test-result-accusations-cost-this-california-cannabis-lab-its-license">testing fraud </a>have also emerged as significant concerns across the cannabis industry.
Michigan's new regulations aim to promote standardization in testing methods and improve oversight. "Randomized audits of licensed labs and shelf products will ensure compliance and maintain consumer trust," Hanna added.
The Michigan legal ecosystem is now composed of 2,198 licenses, most of which are Type C growers (1,841) that are allowed to grow more than 1500 plants. Meanwhile, companies under the Medical Marihuana Facilities Licensing Act and Michigan Regulation and Taxation of Marihuana Act&nbsp;have 38,881 registered employees.
While Michigan's recreational market thrives, its medical cannabis sector has dwindled to less than $1 million in monthly sales. 
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="864" height="419" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04124219/Captura-de-pantalla-2024-12-04-a-las-14.42.14.png" alt="" class="wp-image-677019" style="width:658px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04124219/Captura-de-pantalla-2024-12-04-a-las-14.42.14.png 864w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04124219/Captura-de-pantalla-2024-12-04-a-las-14.42.14-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04124219/Captura-de-pantalla-2024-12-04-a-las-14.42.14-768x372.png 768w" sizes="(max-width: 864px) 100vw, 864px" /></figure>
Cannabis Regulatory Agency <a href="https://www.michigan.gov/cra/-/media/Project/Websites/cra/Agency-Reports/Statistical-Reports/monthly-report/October-2024-Monthly-Report.pdf?rev=28c0604b66a94d68be854eae29e5c247&amp;hash=007A35E1B6542D6FC98991C9DEC46EFE">October Report</a>
Hanna attributed this decline to trends seen in other states with robust adult-use markets though he noted that medical programs still serve a critical niche.
"We still have 84,000 registered patients,&#8221; and there are tax incentives for staying in the medical system, he explained.
<ul>
<li>Read Next: <a href="https://www.benzinga.com/news/retail-sales/24/11/41859954/looking-for-the-best-weed-in-michigan-this-detroit-newspaper-column-has-you-covered">Looking For The Best Weed In Michigan? This Detroit Newspaper Column Has You Covered</a></li>
</ul>
Cover: <a href="https://www.pexels.com/es-es/foto/fotografia-gran-angular-de-la-ciudad-cerca-del-cuerpo-de-agua-702343/">Anon</a> via Pexels

Cannabis

Government

Regulations

Politics

Retail Sales

Markets

Michigan's $10 Billion Cannabis Boom: Insights On Building A Thriving Industry

Spotify Technology SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) released its annual list of the most listened-to songs, albums, artists and podcasts and just like last year it's Taylor Swift's world and we're all <a href="https://www.benzinga.com/general/entertainment/23/11/36031768/taylor-swift-dominates-2023-named-spotifys-top-artist-with-26-1-billion-streams-a-look-at-t">just living in it.</a>
What Happened: For a second straight year, Taylor Swift sits atop the Spotify Wrapped list of the top streamed artists on Spotify with 26.6 billion streams globally. Swift, who set records<a href="https://www.benzinga.com/general/entertainment/23/12/36221025/taylor-swifts-eras-tour-shatters-guinness-record-for-highest-grossing-music-tour-how-much-d"> with her Eras Tour</a> over the last two years, was also the top streamed artist in the U.S.
Shared by Spotify Wednesday, here are the top 10 <a href="https://newsroom.spotify.com/2024-12-04/top-songs-artists-podcasts-audiobooks-albums-trends-2024/">lists </a>for artists, songs, albums and podcasts globally for 2024.
Top Artists 2024:
<ol>
<li>Taylor Swift</li>
<li>The Weeknd</li>
<li>Bad Bunny</li>
<li>Drake</li>
<li>Billie Eilish</li>
<li>Travis Scott</li>
<li>Peso Pluma</li>
<li>Kanye West</li>
<li>Ariana Grande</li>
<li>Feid</li>
</ol>
Top streamed songs 2024:
<ol>
<li>"Espresso" – Sabrina Carpenter</li>
<li>"Beautiful Things" – Benson Boone</li>
<li>"Birds of a Feather" – Billie Eilish</li>
<li>"Gata Only" – FloyyMenor, Cris Mj</li>
<li>"Lose Control" – Teddy Swims</li>
<li>"End of Beginning" – Djo</li>
<li>"Too Sweet" – Hozier</li>
<li>"One Of The Girls (with JENNIE, Lily Rose Depp) – The Weeknd</li>
<li>"Cruel Summer" – Taylor Swift</li>
<li>"Die With A Smile" – Bruno Mars, Lady Gaga</li>
</ol>
Top streamed albums 2024:
<ol>
<li>The Tortured Poets Department: The Anthology – Taylor Swift</li>
<li>Hit Me Hard and Soft – Billie Eilish</li>
<li>Short n' Sweet – Sabrina Carpenter</li>
<li>MAÑANA SERÁ BONITO – Karol G</li>
<li>Eternal Sunshine – Ariana Grande</li>
<li>1989 (Taylor's Version) – Taylor Swift</li>
<li>SOS – SZA</li>
<li>Lover – Taylor Swift</li>
<li>Fireworks &amp; Rollerblades – Benson Boone</li>
<li>Starboy – The Weeknd</li>
</ol>
Top podcasts 2024: &nbsp;
<ol>
<li>The Joe Rogan Experience</li>
<li>Call Her Daddy</li>
<li>Huberman Lab</li>
<li>This Past Weekend with Theo Von</li>
<li>The Diary of a CEO with Steven Bartlett</li>
<li>Serial Killers</li>
<li>Relatos de la Noche</li>
<li>Crime Junkie</li>
<li>Café Com Deus Pai</li>
<li>El Podcast de Marian Rojas Estapé</li>
</ol>
To celebrate Swift's win in 2024, the artist will have a special badge on her Spotify artist profile, the company said.
Read Also: <a href="https://www.benzinga.com/general/entertainment/24/09/40815602/trump-shakes-off-taylor-swifts-harris-endorsement-in-2024-election-shell-probably-pay-a-pri">Trump Shakes Off Taylor Swift&#8217;s Harris Endorsement In 2024 Election: &#8216;She&#8217;ll Probably Pay A Price For It In The Marketplace&#8217;</a>
U.S. Top Lists: Spotify also shared geographical lists where top streaming data can be viewed by some regions and by several of the largest cities in the U.S. Here are the top streamed lists for the U.S.
Top Artists 2024 (U.S.):
<ol>
<li>Taylor Swift</li>
<li>Drake</li>
<li>Zach Bryan</li>
<li>Morgan Wallen</li>
<li>Kanye West</li>
<li>Future</li>
<li>Kendrick Lamar</li>
<li>Travis Scott</li>
<li>The Weeknd</li>
<li>Metro Boomin</li>
</ol>
Top streamed songs 2024 (U.S.):
<ol>
<li>"Espresso" – Sabrina Carpenter</li>
<li>"Not Like Us" – Kendrick Lamar</li>
<li>"A Bar Song (Tipsy)" – Shaboozey</li>
<li>"I Had Some Help (featuring Morgan Wallen)" – Post Malone</li>
<li>"Million Dollar Baby" – Tommy Richman</li>
<li>"Good Luck Babe!" – Chappell Roan</li>
<li>"Beautiful Things" – Benson Boone</li>
<li>"Birds of a Feather" – Billie Eilish</li>
<li>"I Remember Everything (feat. Kacey Musgraves)" – Zach Bryan</li>
<li>"Stick Season" – Noah Kahan</li>
</ol>
Top streamed albums 2024 (U.S.):
<ol>
<li>The Tortured Poets Department: The Anthology – Taylor Swift</li>
<li>One Thing At A Time – Morgan Wallen</li>
<li>Short n' Sweet – Sabrina Carpenter</li>
<li>Stick Season – Noah Kahan</li>
<li>The Rise and Fall of a Midwest Princess – Chappell Roan</li>
<li>Hit Me Hard and Soft – Billie Eilish</li>
<li>SOS – SZA</li>
<li>Dangerous: The Double Album – Morgan Wallen</li>
<li>Zach Bryan – Zach Bryan</li>
<li>1989 (Taylor's Version) – Taylor Swift</li>
</ol>
Top podcasts 2024 (U.S.):
<ol>
<li>The Joe Rogan Experience</li>
<li>Call Her Daddy</li>
<li>This Past Weekend w/ Theo Von</li>
<li>Crime Junkie</li>
<li>The Daily</li>
<li>The Tucker Carlson Show</li>
<li>Huberman Lab</li>
<li>Armchair Expert with Dax Shepard</li>
<li>Smosh Reads Reddit Stories</li>
<li>Shawn Ryan Show</li>
</ol>
Similar to the global charts, Swift dominated the artist and album list for Spotify users in the U.S.
The Winners: Along with Swift, there were multiple winners that can be identified from the list including country music and female artists.
For the business side of things, Universal Music Group NV (OTC:<a class="ticker" href="https://www.benzinga.com/stock/UMGNF#OTC">UMGNF</a>)(OTC:<a class="ticker" href="https://www.benzinga.com/stock/UNVGY#OTC">UNVGY</a>) looks to be a winner. Universal was the record company for many of the top streamed albums or the owner of smaller record labels the artists were on. This includes Taylor Swift, Ariana Grande, Billie Eilish, Sabrina Carpenter, Karol G, The Weeknd, Noah Kahan, Morgan Wallen and Chappell Roan.
Warner Music Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WMG#NASDAQ">WMG</a>) can claim success for Benson Boone and Zach Bryan on the list. Sony Music, a unit of Sony Group Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>), was behind SZA's album.
On the podcast side of things, Joe Rogan dominated both globally and in the U.S., which comes as he is no longer exclusive to Spotify. Rogan was<a href="https://www.benzinga.com/24/11/42221861/joe-rogans-interview-with-donald-trump-cant-put-podcaster-at-top-of-apples-2024-rankings-heres-who-beat-him"> recently ranked third</a> on the Apple podcasts 2024 list, which showed he might not be number one on every platform outside of Spotify.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/earnings-beats/24/11/41945480/spotify-technology-rallies-after-earnings-ample-capacity-for-capital-returns">Spotify Technology Rallies After Earnings: &#8216;Ample Capacity For Capital Returns&#8217;</a></li>
</ul>
Photo: Shutterstock

Entertainment

Global

SPOT

UMGNF

UNVGY

2024 Was World's Taylor Swift Era Once Again: Spotify Reveals Top Artists, Songs, Albums, Podcasts

Mattel shares are trading higher. The company participated in the Morgan Stanley Global Consumer & Retail Conference and reportedly noted Black Friday strength.

Three-time Olympic gold medalist and six-time WNBA All-Star <a href="https://www.benzinga.com/topic/brittney-griner">Brittney Griner</a> will take center stage at the Women Grow 2025 Leadership Summit, scheduled for Feb. 17-18 at the Gaylord National Resort and Convention Center in Maryland, just outside Washington, D.C.
Griner's keynote address, "Cultivating Change: Empowering Women through Personal Leadership," will highlight the Summit's mission to unite women across the cannabis industry to fight for legalization, healthcare rights and gender equity.
In the wake of the 2024 elections, Women Grow is rallying women and their allies to address critical issues facing both the <a href="https://www.benzinga.com/topic/cannabis-industry">cannabis industry</a> and women's access to medical care, including the right to use cannabis as medicine. The Summit aims to foster collaboration across diverse sectors of the cannabis community, emphasizing the need for a collective voice to push for policy change and societal progress.
<h3 class="wp-block-heading">A Call To Band Together For Legalization, Women&#8217;s Rights And Progress</h3>
&#8220;This summit is about more than women fighting for cannabis legalization and women&#8217;s basic rights to medicine," said Dr. <a href="https://www.benzinga.com/markets/cannabis/24/04/38497632/bridging-gaps-women-lead-change-in-cannabis">Chanda Macias</a>, CEO of Women Grow. "It is a sisterhood of power that intentionally supports and trust in one another for the betterment of our country. Now is not the time to be divided.&#8221;
&nbsp;As the cannabis industry continues its rapid global expansion, Women Grow is positioning itself as a leading advocate for aligning industry growth with medical innovation, economic empowerment and social equity. The Summit will provide a platform to advance these goals while calling attention to broader issues affecting women's health and rights.
"Women Grow is calling for a unified voice on issues that affect everyone—our right to shape our health, our businesses, our careers, and our futures," Macias <a href="https://www.prweb.com/releases/with-cannabis-legalization--womens-rights-under-threat-wnba-star--three-time-olympic-gold-medalist-brittney-griner-featured-at-women-grow-2025-leadership-summit-302320588.html">said</a> in a press release. "Together, we can advocate for policies that empower women to make informed choices about their health while pushing for a more inclusive and forward-thinking nation."
The <a href="https://womengrow.com/">Women Grow 2025 Leadership Summit</a> is expected to draw a diverse audience of professionals, entrepreneurs and advocates from across the cannabis space, all united by a shared commitment to progress and equality. 
Now Read:
<ul>
<li><a href="https://www.benzinga.com/24/12/42314121/advocacy-groups-urge-governor-hochul-to-strengthen-leadership-at-new-yorks-office-of-cannabis-management">Advocacy Groups Demand Gov. Hochul Appoint New Leadership For NY&#8217;s Cannabis Office</a></li>
</ul>
Photo courtesy of Women Grow

Events

Brittney Griner To Headline Women Grow 2025 Summit, Advocating For Cannabis Reform And Women's Rights

ADBE

ADEA

BRZE

BTBT

BTDR

CDNS

CFLT

CIFR

CRWD

DDOG

DOCU

DSGX

ESTC

FTNT

HTCR

HUBS

INTU

MNDY

MSTR

NVNI

ORCL

PANW

PATH

PCOR

QUBT

RIOT

SOUN

WDAY

WULF

Shares of stocks in the broader software sector are trading higher. Some names may be moving following better-than-expected earnings from Salesforce and Okta.

Financial giants have made a conspicuous bullish move on e.l.f. Beauty. Our analysis of options history for e.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) revealed 11 unusual trades.
Delving into the details, we found 54% of traders were bullish, while 18% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $95,295, and 8 were calls, valued at $779,769.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $100.0 to $160.0 for e.l.f. Beauty over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for e.l.f. Beauty options trades today is 299.1 with a total volume of 1,333.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for e.l.f. Beauty's big money trades within a strike price range of $100.0 to $160.0 over the last 30 days.
<h3>e.l.f. Beauty 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733342638_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ELF</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$3.8</td>
<td>$3.4</td>
<td>$3.5</td>
<td>$145.00</td>
<td>$350.0K</td>
<td align="right">319</td>
<td>1.0K</td>
</tr>
<tr>
<td>ELF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$33.1</td>
<td>$31.3</td>
<td>$32.81</td>
<td>$125.00</td>
<td>$131.0K</td>
<td align="right">159</td>
<td>75</td>
</tr>
<tr>
<td>ELF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$32.5</td>
<td>$31.3</td>
<td>$32.26</td>
<td>$125.00</td>
<td>$97.2K</td>
<td align="right">159</td>
<td>35</td>
</tr>
<tr>
<td>ELF</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$39.4</td>
<td>$38.9</td>
<td>$39.4</td>
<td>$100.00</td>
<td>$51.2K</td>
<td align="right">202</td>
<td>23</td>
</tr>
<tr>
<td>ELF</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$55.4</td>
<td>$53.2</td>
<td>$54.45</td>
<td>$100.00</td>
<td>$49.0K</td>
<td align="right">127</td>
<td>16</td>
</tr>
</tbody>
</table>

<h3>About e.l.f. Beauty</h3>
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan and cruelty-free cosmetics and skin care products. The Company's mission is to make the best of beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women which include eyeliner, mascara, false eyelashes, lipstick, the foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels. The products that the company sells are marketed under the e.l.f. Cosmetics, W3LL PEOPLE and Keys Soulcare brands. It carries out sales within the US and internationally, out of which maximum revenue is generated from the US.
In light of the recent options history for e.l.f. Beauty, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is e.l.f. Beauty Standing Right Now?</h3>
<ul>
<li>With a volume of 1,525,809, the price of ELF is up 8.16% at $137.81. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 62 days.</li>
</ul>
<h3>What The Experts Say On e.l.f. Beauty</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $164.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Stifel continues to hold a Hold rating for e.l.f. Beauty, targeting a price of $115. 
&#x2A; Maintaining their stance, an analyst from Canaccord Genuity continues to hold a Buy rating for e.l.f. Beauty, targeting a price of $200. 
&#x2A; Maintaining their stance, an analyst from DA Davidson continues to hold a Buy rating for e.l.f. Beauty, targeting a price of $170. 
&#x2A; An analyst from Piper Sandler downgraded its action to Overweight with a price target of $165. 
&#x2A; An analyst from DA Davidson persists with their Buy rating on e.l.f. Beauty, maintaining a target price of $170. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for e.l.f. Beauty, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Check Out What Whales Are Doing With ELF

Financial giants have made a conspicuous bullish move on New Fortress Energy. Our analysis of options history for New Fortress Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) revealed 13 unusual trades.
Delving into the details, we found 53% of traders were bullish, while 38% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $195,375, and 9 were calls, valued at $398,025.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $7.0 to $12.0 for New Fortress Energy during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for New Fortress Energy's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across New Fortress Energy's significant trades, within a strike price range of $7.0 to $12.0, over the past month.
<h3>New Fortress Energy 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733342633_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NFE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/13/24</td>
<td>$0.25</td>
<td>$0.2</td>
<td>$0.25</td>
<td>$10.50</td>
<td>$82.8K</td>
<td>20</td>
<td>3.3K</td>
</tr>
<tr>
<td>NFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.3</td>
<td>$3.0</td>
<td>$3.3</td>
<td>$9.00</td>
<td>$66.0K</td>
<td>863</td>
<td>225</td>
</tr>
<tr>
<td>NFE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$3.2</td>
<td>$3.1</td>
<td>$3.1</td>
<td>$9.00</td>
<td>$62.0K</td>
<td>863</td>
<td>625</td>
</tr>
<tr>
<td>NFE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$1.8</td>
<td>$1.55</td>
<td>$1.75</td>
<td>$12.00</td>
<td>$61.2K</td>
<td>1.2K</td>
<td>391</td>
</tr>
<tr>
<td>NFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$0.95</td>
<td>$0.8</td>
<td>$0.81</td>
<td>$12.00</td>
<td>$52.3K</td>
<td>3.8K</td>
<td>1.0K</td>
</tr>
</tbody>
</table>

<h3>About New Fortress Energy</h3>
New Fortress Energy is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to both lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include terminals and infrastructure, or T&amp;I, and ships.
Following our analysis of the options activities associated with New Fortress Energy, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of New Fortress Energy</h3>
<ul>
<li>Trading volume stands at 5,978,715, with NFE's price up by 8.58%, positioned at $11.46.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 85 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for New Fortress Energy with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

New Fortress Energy's Options Frenzy: What You Need to Know

Whales with a lot of money to spend have taken a noticeably bullish stance on Texas Instruments.
Looking at options history for Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) we detected 19 trades.
If we consider the specifics of each trade, it is accurate to state that 42% of the investors opened trades with bullish expectations and 31% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $367,380 and 11, calls, for a total amount of $756,645.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $180.0 to $230.0 for Texas Instruments over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Texas Instruments's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Texas Instruments's substantial trades, within a strike price spectrum from $180.0 to $230.0 over the preceding 30 days.
<h3>Texas Instruments Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733342628_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TXN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$12.85</td>
<td>$12.5</td>
<td>$12.68</td>
<td>$200.00</td>
<td>$139.4K</td>
<td>467</td>
<td>306</td>
</tr>
<tr>
<td>TXN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$12.75</td>
<td>$12.3</td>
<td>$12.59</td>
<td>$200.00</td>
<td>$109.9K</td>
<td>467</td>
<td>89</td>
</tr>
<tr>
<td>TXN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$8.5</td>
<td>$8.3</td>
<td>$8.5</td>
<td>$195.00</td>
<td>$102.0K</td>
<td>3.3K</td>
<td>426</td>
</tr>
<tr>
<td>TXN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$8.45</td>
<td>$8.25</td>
<td>$8.25</td>
<td>$195.00</td>
<td>$99.0K</td>
<td>3.3K</td>
<td>122</td>
</tr>
<tr>
<td>TXN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/13/24</td>
<td>$0.71</td>
<td>$0.7</td>
<td>$0.7</td>
<td>$190.00</td>
<td>$84.2K</td>
<td>225</td>
<td>1.8K</td>
</tr>
</tbody>
</table>

<h3>About Texas Instruments</h3>
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
After a thorough review of the options trading surrounding Texas Instruments, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Texas Instruments's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 2,248,354, the TXN's price is down by -0.5%, now at $196.24. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 48 days.</li>
</ul>
<h3>Professional Analyst Ratings for Texas Instruments</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $215.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Wells Fargo lowers its rating to Equal-Weight with a new price target of $215.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Texas Instruments, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Texas Instruments's Options: A Look at What the Big Money is Thinking

Teleflex Is Said To Offer €500M To €1B For Biotronik Unit

The Psychedelic Healing Shack in <a href="https://www.benzinga.com/topic/detroit">Detroit</a>, a center promoting spiritual healing with <a href="https://www.benzinga.com/topic/psilocybin">psilocybin mushrooms</a>, is embroiled in a legal battle with the city following a raid in September 2024. The establishment was shut down after an undercover officer allegedly purchased psilocybin mushrooms from owner Robert &#8220;Dr. Bob&#8221; Pizzimenti. As Metro Times <a href="https://www.metrotimes.com/news/psychedelic-healing-shack-battles-detroit-over-religious-use-of-mushrooms-37993230">reported</a>, despite the closure, Pizzimenti remains defiant, arguing that the use of mushrooms is a fundamental part of his religious practice.
<h3 class="wp-block-heading">The City's Legal Response</h3>
In the wake of the raid, Detroit authorities are firm in their stance, threatening to permanently close the Psychedelic Healing Shack unless Pizzimenti agrees to a consent agreement. "It is against the law to sell marijuana without a license," said Conrad Mallett Jr., Detroit's corporation counsel. "It is against the law to sell psychedelic mushrooms." The city claims that Pizzimenti attempted to hide behind religious freedoms to justify illegal activities, a position the city has historically challenged in similar cases.
The raid resulted in the seizure of 99 grams of psilocybin mushrooms and 10 grams of marijuana. Despite the city's actions, Pizzimenti insists that his business, part of his religious practices, is protected under the First Amendment, which guarantees the free exercise of religion.
<h3 class="wp-block-heading">Defending Religious Freedom</h3>
Pizzimenti, a former chiropractor turned spiritual leader, has joined the Sugarleaf Church to bolster his legal defense. The church, founded in 2014, incorporates cannabis and psilocybin mushrooms as sacraments in its spiritual practices. Pizzimenti maintains that the mushrooms serve as a tool for healing, not recreation. &#8220;I see lives change with these mushrooms,&#8221; he says. "They're non-addictive, and I wasn't doing it for the money."
Dr. Bob's argument centers around his belief that the right to use psychedelics as part of religious practices should be protected under the <a href="https://www.congress.gov/bill/103rd-congress/house-bill/1308">Religious Freedom Restoration Act</a>. He asserts that his actions are comparable to the use of wine in Christian communion or peyote in Native American ceremonies. "It's our religious freedom to have these psychedelics," he tells Metro Times.
<h3 class="wp-block-heading">Controversial Legal Battle</h3>
Sugarleaf Church founder, Reverend Heidi Grossman-Lepp, has long advocated for the religious use of entheogens. She was arrested for marijuana-related charges, but the case ended in a hung jury. Grossman-Lepp has since defended over 27 criminal cases, using religious freedom as a key argument. She warned the city of a lawsuit if they continue targeting Pizzimenti, claiming their actions infringe on constitutional rights.
"The city's threats to conduct additional raids and orchestrate controlled buys within the temple blatantly violate his First Amendment right to freely exercise his religion without government interference," Grossman-Lepp wrote in a letter to the city.
<h3 class="wp-block-heading">Legal And Social Debate</h3>
The Psychedelic Healing Shack case has highlighted the ongoing debate over the religious use of psychedelics in the U.S. In cities like Detroit, where psilocybin mushrooms <a href="https://www.benzinga.com/markets/cannabis/21/11/23855295/detroit-decriminalizes-psychedelics-reducing-them-to-lowest-law-enforcement-priority">have been decriminalized</a>, authorities continue to target locations allegedly selling the substance, though no charges have been filed in some cases. Grossman-Lepp argues that the city should focus on more pressing issues, such as local crime, rather than targeting spiritual centers.
"We are not selling drugs; we're offering healing," Pizzimenti concludes. His defiance signals that the battle over religious freedoms and psychedelic use is far from over in Detroit.
Cover image made with AI

Psychedelics

Psilocybin Mushroom Debate Heats Up In Detroit As The City Raids Healing Shack

During the last three months, 4 analysts shared their evaluations of F N B (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNB#NYSE">FNB</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for F N B, presenting an average target of $18.5, a high estimate of $19.00, and a low estimate of $18.00. This current average reflects an increase of 13.85% from the previous average price target of $16.25. 
<img src="https://www.benzinga.com/files/images/story/2024/1733342584_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of F N B among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kelly Motta</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$18.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Timur Braziler</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$19.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Daniel Tamayo</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$19.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Russell Gunther</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Overweight</td>
<td>$18.00</td>
<td>$16.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to F N B. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of F N B compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of F N B's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of F N B's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/FNB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on F N B analyst ratings.</a>
<h2>Delving into F N B's Background</h2>
F N B Corp provides a full range of financial services, principally to consumers, corporations, governments and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management and Insurance. The majority of revenue is from the Community banking segment. It offers commercial &amp; consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets &amp; lease financing. Consumer banking products &amp; services include deposit products, mortgage lending, &amp; consumer lending &amp; a complete suite of mobile &amp; online banking services.
<h3>F N B: Delving into Financials</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: F N B's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 1.23%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 26.7%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 1.78%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): F N B's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.23%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: F N B's debt-to-equity ratio surpasses industry norms, standing at 0.57. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: Simplified</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Beyond The Numbers: 4 Analysts Discuss F N B Stock

RBC Capital raised the firm's price target on Globus Medical (GMED) to $92 from $80 and keeps an Outperform rating on the shares. The company issue...

Globus Medical price target raised to $92 from $80 at RBC Capital

JMP Securities analyst David Turkaly has reiterated their neutral stance on GMED stock, giving a Hold rating on November 11. David Turkaly has give...

Globus Medical's Strong Q3 Performance and Conservative Outlook Justify Hold Rating Amid Merger Challenges

Globus Medical Stock: Re-Rated After A Solid Year

These 19 stocks are poised for tax reform turbocharge - Jefferies

Globus Medical (GMED) announced the commercial launch of the ExcelsiusHub navigation system. ExcelsiusHub joins the expansive ecosystem of Excelsiu...

Comments

Globus Medical

Actualités

Dernières nouvelles pour Globus Medical (NYSE:GMED) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL